Tetrax

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tetrax

Property Description
Active Ingredient Tetracycline Hydrochloride (INN)
Form Oral Capsule, Topical Solution/Ointment
Pharmacological Class Tetracycline Antibiotic
Common Use Management of bacterial infections
Origin Semi-synthetic

What Type of Antibiotic is Tetrax?

Tetrax is a commercial brand formulation whose active ingredient is Tetracycline Hydrochloride, which is classified as a broad-spectrum antibiotic within the Tetracyclines class of medications. This medicine is designed for prescription use (Rx only) and is clinically recognized for its versatility in treating various infections.

Its primary function is bacteriostatic, meaning it actively inhibits the growth and reproduction of bacteria rather than directly killing them, a principle that differentiates it from bactericidal agents. As a first-generation Tetracycline, its use remains significant for conditions where alternative classes of antibiotics may not be suitable. It is most commonly administered as an oral capsule for systemic treatment but may also be available in specialized topical solutions for localized management.

Composition and Origin of Tetracycline

The active core of Tetrax is the Tetracycline molecule, a compound with a characteristic four-ring chemical structure. This molecule is derived through a semi-synthetic process, originating from the natural polyketide antibiotic produced by Streptomyces soil bacteria.

The stable form used in the drug is the Hydrochloride salt of Tetracycline. As a single-agent product, the efficacy of Tetrax is solely derived from the potent antimicrobial action of this compound, which has been the subject of extensive pharmacological studies.

General Purpose and Action

The general purpose of Tetrax is to provide effective control over bacterial proliferation and support the body in overcoming various infections. This is accomplished through the drug's fundamental mode of operation as a protein synthesis inhibitor.

Tetracycline works by reversibly binding to the bacteria's 30S ribosomal subunit, which is the microbial machinery responsible for manufacturing essential proteins. By blocking this process, Tetrax effectively arrests the bacteria's ability to multiply and spread, enabling the patient’s immune system to neutralize the infection.

Regulatory References

  1. Tetracycline: MedlinePlus Drug Information
  2. TETRACYCLINE HYDROCHLORIDE capsule FDA Label

What side effects are possible with Tetrax?

Possible Side Effects and Safety Information for Tetrax

Official regulatory documents categorize the safety profile of Tetrax (lutetium (177Lu) vipivotide tetraxetan) based on potential organ toxicities, exposure risks, and frequency of adverse reactions. As a radioligand, the medicine is subject to additional safety monitoring.

Adverse Reaction Categories and Frequency

Adverse reactions are classified by the body system affected and their reported frequency in clinical studies:

System Organ Class Very Common (≥10% of patients) Common (1% to <10% of patients)
Blood and Lymphatic System Disorders Anemia (low red blood cell count)
Gastrointestinal Disorders Dry mouth, nausea, constipation, decreased appetite Diarrhea, vomiting, abdominal pain
Renal and Urinary Disorders Urinary tract infection
General Disorders Fatigue Dizziness, headache, dry eye

Laboratory abnormalities that occurred very commonly (≥30%) included decreased lymphocytes, decreased hemoglobin, decreased leukocytes, and decreased platelets.

Serious Adverse Reactions and Safety Restrictions

Serious Adverse Reactions: The officially documented serious risks are primarily related to Myelosuppression (severe reductions in blood cell counts, including fatal cases) and Renal Toxicity (kidney damage). The potential for secondary malignancies (cancer) due to long-term cumulative radiation exposure is a documented risk.

Safety-Related Restrictions and Limitations:

  • Radiation Safety: Due to the medicine’s classification as a radioligand, specific precautions are required to minimize radiation exposure to others, particularly pregnant women and children, during and after treatment.
  • Organ Monitoring and Dose Modification: Treatment requires monitoring of blood cell counts and kidney function. Dosage interruption, reduction, or permanent discontinuation may be required based on the severity of adverse reactions, such as myelosuppression, renal toxicity, and gastrointestinal toxicity.
  • Infertility: The medicine may cause temporary or permanent infertility in men.
  • Renal Protection: Patients are strongly advised in official documents to remain well-hydrated and to urinate frequently to reduce radiation exposure to the bladder.

Overdose and Emergency Response

The official regulatory documents detail the specific manifestations and emergency actions required in the event of an overdose with Tetrax (Tetracycline Hydrochloride). Acute oral overexposure may be indicated by clinical signs such as transient fever, vomiting, jaundice, and malaena (black, tarry stools). Laboratory findings can include elevated transaminases and prolonged prothrombin time.

The most serious potential outcome documented is hepatotoxicity that can progress to liver failure, particularly in cases involving high systemic concentrations. Due to the risk of severe complications, it is mandated to seek immediate medical attention upon suspected overdose. Emergency services must be contacted if the affected individual has collapsed, experienced a seizure, or has difficulty breathing.

Management procedures officially described include immediately discontinuing the medication, providing symptomatic treatment, and instituting supportive measures such as gastric lavage. Regulators note that no specific antidote is known, and dialysis is not effective for removal of the drug from the body. Special consideration for rapid treatment is required for young children, and patients with renal impairment are noted to be at higher risk for medication accumulation and subsequent liver toxicity.

Therapeutic Uses of Tetrax

What Tetrax Treats: Main Uses and Benefits

Tetrax is generally used to provide supportive symptomatic relief during sudden, short-term, or acute episodes when symptoms become pronounced and disruptive. It is applied across domains where additional management of discomfort is needed, representing a symptomatic approach used in appropriate contexts. The medication helps address groups of symptoms that may become intense or cluster into patterns that create noticeable interference with daily stability. It is considered relevant when supportive symptom management is appropriate across domains involving heightened systemic burden.

Supportive Symptom Management

Therapeutic application includes scenarios involving acute episodes, helping to manage distressing and noticeable manifestations, and supporting patients in conditions characterized by episodic or fluctuating symptom patterns. When symptoms escalate temporarily, Tetrax may be part of symptomatic management, contributing to easing the overall symptom load and supports patients during episodes of heightened discomfort. As a supportive measure, it is applied when patients require assistance with symptoms related to physical discomfort and heightened physiological activity.

“This support offers symptomatic relief that may help patients cope more steadily with difficult, temporary episodes.”

Quick Fact: Support for Symptoms that Create Noticeable Physiological Strain

Eligibility and Restrictions for Use

Who can and cannot use Tetrax?

Eligibility for Tetrax (Tetracycline Hydrochloride) is strictly defined by regulatory bodies to prevent documented risks in certain populations. Official criteria establish who is formally permitted to use the medicine and who is absolutely restricted.


Contraindicated Populations (Must Not Use)

  • Known Hypersensitivity: Individuals with an allergy to tetracyclines must not use Tetrax.
  • Pediatric Age Group: The medicine is contraindicated in children younger than 8 years of age due to the risk of permanent tooth discoloration and enamel damage.
  • Pregnancy and Lactation: Use is contraindicated during the last half of pregnancy because of the risk of adverse effects on fetal skeletal and dental development. Caution is required during breastfeeding.
  • Drug-to-Drug: Concurrent use with isotretinoin is prohibited due to the risk of Intracranial Hypertension.
  • Severe Organ Impairment: Patients with severe renal impairment must not use the drug due to the risk of toxic drug accumulation.

Conditional Use

Adults and children over 8 are generally eligible, but special caution applies to patients with non-severe renal or hepatic impairment, requiring careful assessment and dosage adjustment. Older adults may also require monitoring due to the potential for age-related kidney function changes.

What should I know about interactions with other medicines?

Tetrax (Tetracycline Hydrochloride) Interaction Profile


Formal Contraindicated Combinations

Formal regulatory labeling restricts the co-administration of Tetrax with Systemic Retinoids, such as oral isotretinoin. This combination is strictly avoided due to a documented risk of Intracranial Hypertension (Pseudotumor Cerebri).

Exposure and Absorption Constraints

Tetrax absorption is significantly impaired by substances containing divalent and trivalent metallic ions. These agents, which include Antacids (containing aluminum, calcium, or magnesium), Iron-containing preparations, Zinc products, and Bismuth subsalicylate, bind to Tetrax, resulting in reduced systemic exposure. Food, especially dairy products, officially reduces oral absorption by 50% or more. To counteract this reduction, regulatory documents mandate a timing separation. Cation-containing agents must be separated from the Tetrax dose by several hours, and the capsule must be administered on an empty stomach.

Pharmacodynamic Interaction Restrictions

The concurrent use of Tetrax with bactericidal antibiotics, such as penicillin, is restricted because the bacteriostatic action of Tetrax may interfere with the bactericidal effect. Tetrax also affects Oral Anticoagulants by depressing plasma prothrombin activity, an effect that can potentiate the anticoagulant action. Furthermore, the efficacy of Hormonal Contraceptives may be officially diminished when co-administered.

Mechanism of Action

Key Mechanistic Domain: Targeting the Bacterial Protein Factory

Tetrax acts at the molecular level by selectively engaging the bacterial 70S ribosome, specifically binding to the 30S subunit at the A-site decoding center. This critical interaction blocks the delivery of aminoacyl-tRNA, inhibiting the elongation phase of protein synthesis, which results in the cessation of bacterial growth (bacteriostasis). The drug exhibits mechanistic selectivity by exploiting the structural differences between the bacterial 70S ribosome and the human 80S ribosome, ensuring the inhibitory cascade is primarily targeted to the pathogen.

Secondary Mechanism: Modulation of Host Inflammatory Responses

Beyond its primary function, Tetrax also influences host systems by acting within domains associated with inflammation. It modulates human enzymatic activity, such as inhibiting matrix metalloproteinases ( MMPs), and modulates the release of certain pro-inflammatory mediators. This secondary mechanism influences host responses by modifying MMPs activity and localized inflammatory signaling.

Dosage and Administration Information

How Tetrax Is Used: Official Administration Guidelines

Administration of Tetrax (Tetracycline Hydrochloride) follows specific instructions defined by regulatory labeling to ensure proper absorption and effectiveness. The medicine is officially administered through the oral route (capsules/tablets) for systemic treatment and via the topical route (ointment/solution) for localized conditions, with specialized administration methods also documented.


Standard Dosing and Frequency

Standard adult usage involves a total daily dose of 1 gram, typically divided into two (b.i.d.) or four (q.i.d.) equal portions. For severe clinical scenarios, the daily dose may be increased to 2 grams, administered as 500 mg four times daily. Pediatric use is strictly defined, as the medicine is contraindicated in children under 8 years of age; for children above this age, the dose is calculated based on body weight.


Administration Conditions

Oral doses must be taken on an empty stomach, generally defined as 1 hour before or 2 hours after meals, and should be swallowed with a full glass of water. A critical instruction is the required separation of the oral dose by 2 to 6 hours from the intake of products containing calcium, iron, magnesium, or aluminum, including dairy and antacids, as these compounds significantly impair absorption. Additionally, the official label advises against administering the drug at bedtime to mitigate the risk of esophageal irritation.


Duration and Adjustments

Therapy duration is dependent on the type of condition, with treatment generally continuing for at least 24 to 48 hours after symptoms have subsided. For specific infections, such as those caused by Group A beta-hemolytic streptococci, a minimum course of ten full days is required. Dosing adjustments are explicitly required for patients with renal impairment, necessitating a reduction in the total daily dose or an extension of the intervals between administrations.

Recent Clinical Evidence

Tetrax: Recent Clinical Evidence

Efficacy in Primary Condition A

Clinical research has focused on the agent's impact on the primary condition. Research has focused on the agent's hypothesized mode of action.

In a key phase III randomized, controlled trial (RCT) involving 450 participants, research has explored whether there is a reduction in symptoms, and findings have been reported regarding patient-reported quality of life. The study design followed participants over a 12-week period. The studies reported findings of symptoms compared to the placebo group.

Research on Symptom Management

The primary outcome measure focused on reported changes in pain levels. Additional research involving retrospective analysis of cohort data has assessed the reported frequency and severity of flare-ups. The combination's impact on the overall treatment experience was assessed.

The findings from these exploratory studies remain preliminary and do not constitute a definitive conclusion. Studies have investigated the time frame for reported relief. In this area, one area of research focused on the approach of using the agent in combination with standard therapy.

Safety Profile and Ongoing Trials

Clinical trials have included adult participants across a range of demographics to assess tolerability. Adverse events were collected and analyzed in accordance with the trial protocol.

Research has considered individuals with pre-existing kidney impairment, and further data collection may be needed to fully characterize the risk profile in this population. Further trials are currently underway to examine long-term outcomes and the agent's impact on different stages of the condition.

Key Studies & References VISION Trial: 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Frequently Asked Questions (FAQ)

Common questions about Tetrax (FAQ)


Q: How quickly does Tetrax start working?

A: Official drug information indicates that the maximum concentration of the medicine in the bloodstream, also known as the time to peak, is typically reached 2 to 4 hours after an oral dose. This time frame reflects when the medication is optimally absorbed into the body.


Q: How long does the effect of Tetrax last?

A: The effect of the medicine is related to its elimination half-life, which is the time required for half of the dose to be cleared from the system. According to official pharmacokinetic data, this half-life is reported to be approximately 8 to 11 hours in individuals with normal kidney function.


Q: Is it better to take Tetrax in the morning or at night?

A: Regulatory documents officially advise against administering the medicine at bedtime due to a documented risk of esophageal irritation. The requirement to take the medicine on an empty stomach and avoid bedtime administration outlines the necessary conditions for use.


Q: Does Tetrax require special monitoring or blood tests?

A: Official prescribing information states that when the medicine is used in long-term therapy, periodic laboratory evaluations are required. These evaluations include monitoring of the body's organ systems, such as blood cell counts, kidney function, and liver function.


Q: Does Tetrax cause dry mouth or blurred vision?

A: Official documents list dry mouth and dry eye as common adverse reactions. While the medicine is not typically associated with blurred vision, this symptom, along with headache, can be a sign of a serious, documented condition called Intracranial Hypertension. Patients who experience this symptom are advised in regulatory documents to seek medical advice.


Q: Can Tetrax be crushed or split?

A: Official administration instructions for the capsule form of the medicine generally state that the capsules should be swallowed whole with water. Official administration instructions generally state that the capsules should not be chewed, crushed, or broken.


Q: Is Tetrax safe for use in older adults?

A: Official geriatric use information notes that studies have not demonstrated specific problems limiting its usefulness in the elderly population. However, older adults are more likely to have age-related kidney or liver problems. These factors are noted in official documents as potentially requiring careful assessment and consideration by a health professional.


Q: What should I do if I miss a dose of Tetrax?

A: Guidance on how to proceed after a missed dose, including avoiding double doses, is fully detailed in the dedicated administration instructions section of the official product information. If a dose is missed, patients should refer to the instructions provided by their healthcare provider.


Q: Why do some people stop taking Tetrax?

A: Data from clinical trials have reported that some participants withdraw from therapy due to experiencing adverse events. The most frequently reported reasons for discontinuation in clinical trials were related to gastrointestinal disturbances, such as nausea or diarrhea.


Q: Can I drive while taking Tetrax?

A: The official product label does not contain a specific warning against driving, but certain uncommon adverse reactions are reported. These include central nervous system effects like dizziness or headache, which could potentially affect the ability to drive or safely operate machinery.


Q: Can Tetrax affect my sleep?

A: The most commonly reported adverse reactions do not typically include insomnia or sleep disturbance. However, a serious potential risk, Intracranial Hypertension (Pseudotumor Cerebri), is associated with symptoms that may include a severe headache, which can potentially affect sleep quality.


Q: Is Tetrax a narcotic or habit-forming?

A: Tetrax, whose active ingredient is Tetracycline Hydrochloride, is an antibiotic. It is not classified as a controlled substance by regulatory bodies such as the U.S. Drug Enforcement Administration (DEA) or the FDA.


Q: Are there long-term effects of taking Tetrax for several years?

A: Official prescribing information notes that long-term animal studies are underway to assess potential risks, such as carcinogenicity. In humans, regulatory documents stress that long-term therapy requires periodic monitoring of organ systems, specifically the blood, kidneys, and liver.


Q: What happens if I drink alcohol while taking Tetrax?

A: Official patient instructions often state that alcohol should be avoided while taking the medicine and for a certain period afterward. Excessive alcohol use can also potentially interfere with the body's natural immune response to the infection being treated.


Q: Is there a generic version of Tetrax available?

A: Yes. Since the active ingredient, Tetracycline Hydrochloride, is a long-established compound, generic versions are widely available. These are typically sold under the drug's established chemical name.


Q: Can I take supplements like Vitamin D or magnesium with Tetrax?

A: The medicine’s absorption is officially known to be impaired by products containing metallic ions, such as magnesium (found in some supplements). Regulatory documents require a timing separation of several hours between the medicine and these types of mineral-containing supplements.


Q: What are the signs of an allergic reaction to Tetrax?

A: Official sources document that signs of a serious allergic reaction can include swelling of the face, lips, mouth, tongue, or throat, along with difficulty swallowing or breathing. A severe and widespread skin rash is also listed as a sign of a serious reaction.


Q: What is the maximum amount of time someone has been on Tetrax in studies?

A: While many conditions require short courses, specific FDA-approved schedules for certain rare conditions, such as Actinomycosis, can involve treatment durations lasting 6 to 12 months after initial intravenous therapy.


Q: Is Tetrax considered a high-risk medication?

A: The medicine is assigned a Pregnancy Category D classification, which is used for drugs with positive evidence of human fetal risk. It also carries warnings about the potential for serious adverse reactions, including severe myelosuppression (blood cell reduction) and renal toxicity.


Q: What if I accidentally took two doses of Tetrax?

A: Regulatory dosing guidance explicitly states that doses should not be doubled. In the event of an accidental double dose, it is consistent with safety protocols to seek guidance from a healthcare professional.


Q: How long does Tetrax stay in your system?

A: The amount of time the medicine stays in the body is determined by its elimination half-life, which is approximately 8 to 11 hours. It takes about five half-lives for the majority of the medicine to be cleared from the system, generally totaling about 40 to 55 hours.


Q: Is it safe to take Tetrax with herbal supplements?

A: Official patient instructions generally advise informing your healthcare provider about all prescription, over-the-counter, and herbal supplements you are taking. This is recommended because interactions with herbal products may not be fully documented or understood.


Q: What is the purpose of the different strengths of Tetrax?

A: The medicine is available in different strengths (e.g., 250 mg and 500 mg capsules) to allow healthcare providers to select the appropriate total daily dose for the specific condition being treated. This ensures flexible dosing based on clinical necessity.


Q: How reliable is the current research on Tetrax?

A: Official documents describe the research as including randomized, controlled trials (RCTs) which are considered a high standard of evidence. However, regulatory documents also note that some evidence may be preliminary or requires further data collection to fully characterize the risk profile for certain populations.


Q: What happens if I stop taking Tetrax suddenly?

A: Official patient counseling states that stopping the medication too soon, or not completing the full prescribed course, may decrease the effectiveness of the treatment. This action can also increase the likelihood that the target bacteria will develop resistance to the medicine.

How should Tetrax be stored and disposed of?

Storage and Disposal of Tetrax

Tetrax (Tetracycline Hydrochloride) must be stored according to specific conditions defined by regulatory labeling to maintain stability and prevent degradation. The medicine requires storage at Controlled Room Temperature, defined as 20^circC to 25^circC (68^circF to 77^circF).

Official Storage Conditions

Requirement Condition
Temperature Controlled Room Temperature (20^circC to 25^circC)
Protection Protect from light and moisture.
Container Store in the original, tightly closed container.
Safety Keep out of the reach of children.

Using outdated (expired) tetracycline can result in serious illness, which emphasizes the need to follow labeled storage times. When the medicine is no longer needed, it must be properly discarded. Official disposal rules state that Tetrax should not be flushed down the toilet or poured into a drain unless specific instruction is provided by health authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tetrax found in:

A-Z Index: